TG
KPTI icon

TCW Group’s Karyopharm Therapeutics KPTI Stock Holding History

TCW Group’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,719
Closed -$439K – 342
2018
Q3 		$439K Sell
1,719
-1
-0.1% -$276 ﹤0.01% 307
2018
Q2 		$438K Sell
1,720
-1,177
-41% -$291K ﹤0.01% 301
2018
Q1 		$583K Buy
2,897
+187
+7% +$37.3K ﹤0.01% 297
2017
Q4 		$390K Hold
2,710
– – ﹤0.01% 355
2017
Q3 		$446K Hold
2,710
– – ﹤0.01% 357
2017
Q2 		$368K Hold
2,710
– – ﹤0.01% 370
2017
Q1 		$522K Hold
2,710
– – ﹤0.01% 354
2016
Q4 		$382K Hold
2,710
– – ﹤0.01% 650
2016
Q3 		$396K Sell
2,710
-67
-2% -$8.05K ﹤0.01% 622
2016
Q2 		$279K Hold
2,777
– – ﹤0.01% 664
2016
Q1 		$372K Sell
2,777
-222
-7% -$24.5K ﹤0.01% 654
2015
Q4 		$596K Buy
2,999
+167
+6% +$36.2K ﹤0.01% 615
2015
Q3 		$447K Sell
2,832
-1,334
-32% -$357K ﹤0.01% 648
2015
Q2 		$1.7M Sell
4,166
-5,093
-55% -$2.2M 0.01% 424
2015
Q1 		$4.25M Sell
9,259
-1,944
-17% -$838K 0.02% 420
2014
Q4 		$6.29M Buy
11,203
+2,063
+23% +$1.17M 0.03% 350
2014
Q3 		$4.79M Buy
9,140
+1,004
+12% +$567K 0.02% 495
2014
Q2 		$5.68M Sell
8,136
-231
-3% -$108K 0.02% 459
2014
Q1 		$3.88M Sell
8,367
-7,715
-48% -$3.91M 0.02% 555
2013
Q4 		$5.53M Buy
+16,082
New +$4.44M 0.02% 473

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCW Group's KPTI Position: Q4 2018 in Review

TCW Group sold out of Karyopharm Therapeutics (KPTI) in Q4 2018, closing a stake of 1,719 shares — an estimated $439K sold.

TCW Group first reported a position in KPTI in Q4 2013 and held it in 20 quarters. The position peaked at $6.29M in Q4 2014. 115 funds tracked by Wall St. Rank hold KPTI as of Q4 2018.

  • TCW Group reported no remaining Karyopharm Therapeutics position as of Q4 2018 after selling out during the quarter.
  • TCW Group sold 1,719 Karyopharm Therapeutics shares in Q4 2018, an estimated $439K.
  • TCW Group first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 20 quarters.
  • TCW Group's Karyopharm Therapeutics position peaked at $6.29M in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2018.

Based on TCW Group's 13F filing for Q4 2018, filed 11 Feb 2019.